Tag: CLTI

Richard Neville

Global vascular guidelines for CLTI are gaining traction but work remains...

The application of new global vascular guidelines for chronic limb-threatening ischaemia (CLTI) provides an opportune and worthwhile window to revisit the concept of critical...
vascular limb salvage clinic in Leicester

Vascular limb salvage (VaLS) clinic helps to meet the VSGBI time-to-treatment...

Described as “deliberately challenging”, the new time-to-treatment targets published by the Vascular Society of Great Britain and Ireland (VSGBI), as part of the Peripheral...
LimFlow promise II

First CLTI patient enrolled in PROMISE II pivotal study of LimFlow...

LimFlow, a specialist in minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), has announced...

LimFlow receives FDA approval for US study of minimally-invasive technology designed...

LimFlow has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) for the PROMISE II pivotal study of...